CN102458665A - 用于从生物学样品中分离靶生物实体的方法和仪器 - Google Patents
用于从生物学样品中分离靶生物实体的方法和仪器 Download PDFInfo
- Publication number
- CN102458665A CN102458665A CN2010800262983A CN201080026298A CN102458665A CN 102458665 A CN102458665 A CN 102458665A CN 2010800262983 A CN2010800262983 A CN 2010800262983A CN 201080026298 A CN201080026298 A CN 201080026298A CN 102458665 A CN102458665 A CN 102458665A
- Authority
- CN
- China
- Prior art keywords
- magnetic
- flow path
- fluid flow
- module
- separation module
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012472 biological sample Substances 0.000 title claims abstract description 89
- 238000000034 method Methods 0.000 title claims abstract description 82
- 230000005291 magnetic effect Effects 0.000 claims abstract description 263
- 238000000926 separation method Methods 0.000 claims abstract description 165
- 239000012530 fluid Substances 0.000 claims abstract description 138
- 239000003446 ligand Substances 0.000 claims abstract description 44
- 230000027455 binding Effects 0.000 claims abstract description 13
- 239000000523 sample Substances 0.000 claims description 95
- 239000006249 magnetic particle Substances 0.000 claims description 75
- 210000004027 cell Anatomy 0.000 claims description 67
- 210000004369 blood Anatomy 0.000 claims description 48
- 239000008280 blood Substances 0.000 claims description 48
- 239000002245 particle Substances 0.000 claims description 44
- 150000001875 compounds Chemical class 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 24
- 108020004707 nucleic acids Proteins 0.000 claims description 16
- 102000039446 nucleic acids Human genes 0.000 claims description 16
- 150000007523 nucleic acids Chemical class 0.000 claims description 16
- 238000012360 testing method Methods 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 15
- 238000011084 recovery Methods 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 210000004881 tumor cell Anatomy 0.000 claims description 10
- 230000008878 coupling Effects 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 8
- 238000005336 cracking Methods 0.000 claims description 7
- 210000004698 lymphocyte Anatomy 0.000 claims description 7
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 claims description 6
- 230000000740 bleeding effect Effects 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 150000002910 rare earth metals Chemical class 0.000 claims description 6
- 230000003068 static effect Effects 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- 230000004087 circulation Effects 0.000 claims description 5
- 210000002381 plasma Anatomy 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 108091005461 Nucleic proteins Proteins 0.000 claims description 3
- 230000001605 fetal effect Effects 0.000 claims description 3
- 230000000781 anti-lymphocytic effect Effects 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 25
- 239000003153 chemical reaction reagent Substances 0.000 description 16
- 238000004140 cleaning Methods 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 10
- 239000011324 bead Substances 0.000 description 10
- 239000007853 buffer solution Substances 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 9
- 239000007788 liquid Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 239000004816 latex Substances 0.000 description 6
- 229920000126 latex Polymers 0.000 description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 6
- 239000004810 polytetrafluoroethylene Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000005298 paramagnetic effect Effects 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 210000001768 subcellular fraction Anatomy 0.000 description 4
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 3
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 230000005415 magnetization Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- 229920002379 silicone rubber Polymers 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 208000015634 Rectal Neoplasms Diseases 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 206010038038 rectal cancer Diseases 0.000 description 2
- 201000001275 rectum cancer Diseases 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 101710186708 Agglutinin Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 210000005266 circulating tumour cell Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- UCNNJGDEJXIUCC-UHFFFAOYSA-L hydroxy(oxo)iron;iron Chemical compound [Fe].O[Fe]=O.O[Fe]=O UCNNJGDEJXIUCC-UHFFFAOYSA-L 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940113601 irrigation solution Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004882 non-tumor cell Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000005408 paramagnetism Effects 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000009428 plumbing Methods 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/28—Magnetic plugs and dipsticks
- B03C1/288—Magnetic plugs and dipsticks disposed at the outer circumference of a recipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/005—Pretreatment specially adapted for magnetic separation
- B03C1/01—Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/18—Magnetic separation whereby the particles are suspended in a liquid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/26—Details of magnetic or electrostatic separation for use in medical or biological applications
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17153209P | 2009-04-22 | 2009-04-22 | |
| US61/171,532 | 2009-04-22 | ||
| US18266109P | 2009-05-29 | 2009-05-29 | |
| US61/182,661 | 2009-05-29 | ||
| US28528609P | 2009-12-10 | 2009-12-10 | |
| US61/285,286 | 2009-12-10 | ||
| PCT/AU2010/000459 WO2010121315A1 (en) | 2009-04-22 | 2010-04-22 | Method and apparatus for isolating a target bioentity from a biological sample |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102458665A true CN102458665A (zh) | 2012-05-16 |
Family
ID=43010599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010800262983A Pending CN102458665A (zh) | 2009-04-22 | 2010-04-22 | 用于从生物学样品中分离靶生物实体的方法和仪器 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120115167A1 (https=) |
| EP (1) | EP2421654A1 (https=) |
| JP (1) | JP2012524885A (https=) |
| CN (1) | CN102458665A (https=) |
| AU (1) | AU2010239154A1 (https=) |
| IL (1) | IL215807A0 (https=) |
| NZ (1) | NZ595982A (https=) |
| RU (1) | RU2011147219A (https=) |
| WO (1) | WO2010121315A1 (https=) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102911864A (zh) * | 2012-10-15 | 2013-02-06 | 宁波美晶医疗技术有限公司 | 一种血液中稀有细胞的分离仪 |
| CN103131693A (zh) * | 2013-02-25 | 2013-06-05 | 宁波美晶医疗技术有限公司 | 一种血液中稀有细胞的分离方法 |
| CN103131634A (zh) * | 2013-02-25 | 2013-06-05 | 宁波美晶医疗技术有限公司 | 一种基于微磁场的免疫肿瘤细胞筛选系统 |
| CN103940997A (zh) * | 2014-03-21 | 2014-07-23 | 上海柏慧康生物科技有限公司 | 一种乳腺癌循环肿瘤细胞检测系统及试剂盒 |
| CN115655825A (zh) * | 2015-09-18 | 2023-01-31 | 紫荆实验室股份有限公司 | 利用表面附着结构的流动池，以及相关的系统和方法 |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20171468T1 (hr) * | 2010-11-09 | 2017-12-15 | Arcedi Biotech Aps | Obogaćivanje i identificiranje fetalnih stanica u majčinskoj krvi, te ligandi namijenjenu u tu svrhu |
| WO2012113028A1 (en) * | 2011-02-23 | 2012-08-30 | Clinical Genomics Pty. Ltd. | Isolation of a target bioentity from a biological sample |
| US20140295420A1 (en) * | 2011-06-15 | 2014-10-02 | Koninklijke Philips N.V. | Processing of biological sample components |
| WO2013003898A1 (en) * | 2011-07-07 | 2013-01-10 | Clinical Genomics Pty. Ltd | Method for detection of cancer in a patient |
| DE102011088741B4 (de) | 2011-12-15 | 2013-07-25 | Institut für Bioprozess- und Analysenmesstechnik e.V. | Verfahren und Anordnung zum Markieren und Separieren von Zellen aus einer Zellsuspension |
| WO2013123035A1 (en) | 2012-02-13 | 2013-08-22 | Molecular Systems Corporation | System and method for processing and detecting nucleic acids |
| US9604213B2 (en) | 2012-02-13 | 2017-03-28 | Neumodx Molecular, Inc. | System and method for processing and detecting nucleic acids |
| US11648561B2 (en) | 2012-02-13 | 2023-05-16 | Neumodx Molecular, Inc. | System and method for processing and detecting nucleic acids |
| US9637775B2 (en) | 2012-02-13 | 2017-05-02 | Neumodx Molecular, Inc. | System and method for processing biological samples |
| US20140024136A1 (en) * | 2012-07-19 | 2014-01-23 | Derek L. Chappell | Magnetic particle separator |
| US20140120544A1 (en) | 2012-10-25 | 2014-05-01 | Neumodx Molecular, Inc. | Method and materials for isolation of nucleic acid materials |
| EP3058316B1 (en) * | 2013-10-18 | 2019-03-13 | The General Hospital Corporation | Microfluidic sorting using high gradient magnetic fields |
| US10690662B2 (en) | 2014-11-28 | 2020-06-23 | Indian Institute Of Technology Delhi | Magnetic capturing of rare cells |
| EP3061529A1 (en) * | 2015-02-24 | 2016-08-31 | AdnaGen GmbH | Apparatus and method for the analysis, isolation and/or enrichment of target structures in a fluid sample |
| WO2016183032A1 (en) | 2015-05-08 | 2016-11-17 | Biomagnetic Solutions Llc | Apparatus and method for immunomagnetic cell separation |
| WO2017053630A1 (en) * | 2015-09-22 | 2017-03-30 | Purdue Research Foundation | Centrifuge-free isolation and detection of rare cells |
| EP3735281B1 (en) | 2018-01-05 | 2024-11-27 | Path Ex, Inc. | Device for the capture and removal of disease material from fluids |
| JP7396777B2 (ja) * | 2018-09-28 | 2023-12-12 | オクタン バイオテック インコーポレーテッド | 磁気分離 |
| EP3870969A4 (en) * | 2018-10-24 | 2022-07-27 | Path Ex, Inc. | PROCESS FOR RECOVERING AND ISOLATION OF DISEASE MATERIAL FROM FLOWING MATERIAL |
| IL308999B2 (en) | 2019-06-07 | 2026-02-01 | Arcedi Biotech Aps | Isolation of fetal cells using FACS |
| JP2022545485A (ja) * | 2019-08-30 | 2022-10-27 | フロデザイン ソニックス， インク． | 複数の標的受容体のための音響親和性細胞の選択 |
| CN113125707A (zh) * | 2020-01-10 | 2021-07-16 | 陈琪 | 一种分离磁微粒的方法、装置及设备 |
| EP4616195A1 (en) * | 2022-11-08 | 2025-09-17 | Zhong Li | Methods for detecting target compounds and uses thereof |
| CN120838569B (zh) * | 2025-07-30 | 2026-01-06 | 上海迪化科技股份有限公司 | 一种磁珠连续分离工艺及装置 |
| CN120644311B (zh) * | 2025-07-30 | 2026-02-06 | 上海迪化科技股份有限公司 | 一种磁珠连续分离系统和控制方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795470A (en) * | 1991-03-25 | 1998-08-18 | Immunivest Corporation | Magnetic separation apparatus |
| CN1506460A (zh) * | 2002-12-09 | 2004-06-23 | �廪��ѧ | 从样品中分离细胞粒子的方法及其试剂盒 |
| CN1899698A (zh) * | 2006-06-30 | 2007-01-24 | 上海师范大学 | 磁性分离柱及其在生物样品分离中的应用 |
| WO2009026566A1 (en) * | 2007-08-23 | 2009-02-26 | Cynvenio Biosystems, Llc | Trapping magnetic sorting system for target species |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1575805A (en) * | 1976-03-12 | 1980-10-01 | Technicon Instr | Automatic diagnostic apparatus |
| AU2613988A (en) * | 1988-01-04 | 1989-08-01 | E.I. Du Pont De Nemours And Company | Multiple stage affinity process for isolation of specific cells from a cell mixture |
| JP3962789B2 (ja) * | 1995-02-21 | 2007-08-22 | ダブリュー． シディキー，イクバール | 磁性粒子を利用した混合／分離装置及びその方法 |
| US5705059A (en) * | 1995-02-27 | 1998-01-06 | Miltenyi; Stefan | Magnetic separation apparatus |
| FR2748569B1 (fr) * | 1996-05-07 | 1998-08-07 | Biocom Sa | Procede et installation de separation de particules magnetiques dans un fluide pour l'analyse biologique, et application dudit procede |
| US20030095897A1 (en) * | 2001-08-31 | 2003-05-22 | Grate Jay W. | Flow-controlled magnetic particle manipulation |
| US7553625B2 (en) * | 2003-12-22 | 2009-06-30 | John Wayne Cancer Institute | Method and apparatus for in vivo collection of circulating biological components |
| JP2006010529A (ja) * | 2004-06-25 | 2006-01-12 | Canon Inc | 磁性粒子分離装置および分離方法 |
| JP2006051850A (ja) * | 2004-08-10 | 2006-02-23 | Matsushita Electric Ind Co Ltd | 運転支援装置及び運転支援方法 |
| CA2651367A1 (en) * | 2005-05-11 | 2006-11-16 | Genetic Technologies Limited | Methods of enriching fetal cells |
| JP2007010500A (ja) * | 2005-06-30 | 2007-01-18 | Canon Inc | サンプル検出装置とそれを含む検体分析装置 |
| WO2007092713A2 (en) * | 2006-02-02 | 2007-08-16 | Trustees Of The University Of Pennsylvania | Microfluidic system and method for analysis of gene expression in cell-containing samples and detection of disease |
| WO2007106013A1 (en) * | 2006-03-13 | 2007-09-20 | Gyros Patent Ab | Enhanced magnetic particle steering |
| WO2009117611A2 (en) * | 2008-03-19 | 2009-09-24 | Cynvenio Biosystems, Llc | Trapping magnetic cell sorting system |
| US20110137018A1 (en) * | 2008-04-16 | 2011-06-09 | Cynvenio Biosystems, Inc. | Magnetic separation system with pre and post processing modules |
| US8377669B2 (en) * | 2009-11-17 | 2013-02-19 | Abbott Point Of Care Inc. | Reducing leukocyte interference in non-competitive immunoassays |
-
2010
- 2010-04-22 JP JP2012506281A patent/JP2012524885A/ja not_active Ceased
- 2010-04-22 RU RU2011147219/15A patent/RU2011147219A/ru not_active Application Discontinuation
- 2010-04-22 CN CN2010800262983A patent/CN102458665A/zh active Pending
- 2010-04-22 AU AU2010239154A patent/AU2010239154A1/en not_active Abandoned
- 2010-04-22 WO PCT/AU2010/000459 patent/WO2010121315A1/en not_active Ceased
- 2010-04-22 NZ NZ595982A patent/NZ595982A/xx not_active IP Right Cessation
- 2010-04-22 US US13/265,674 patent/US20120115167A1/en not_active Abandoned
- 2010-04-22 EP EP10766508A patent/EP2421654A1/en not_active Withdrawn
-
2011
- 2011-10-23 IL IL215807A patent/IL215807A0/en unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795470A (en) * | 1991-03-25 | 1998-08-18 | Immunivest Corporation | Magnetic separation apparatus |
| CN1506460A (zh) * | 2002-12-09 | 2004-06-23 | �廪��ѧ | 从样品中分离细胞粒子的方法及其试剂盒 |
| CN1899698A (zh) * | 2006-06-30 | 2007-01-24 | 上海师范大学 | 磁性分离柱及其在生物样品分离中的应用 |
| WO2009026566A1 (en) * | 2007-08-23 | 2009-02-26 | Cynvenio Biosystems, Llc | Trapping magnetic sorting system for target species |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102911864A (zh) * | 2012-10-15 | 2013-02-06 | 宁波美晶医疗技术有限公司 | 一种血液中稀有细胞的分离仪 |
| CN103131693A (zh) * | 2013-02-25 | 2013-06-05 | 宁波美晶医疗技术有限公司 | 一种血液中稀有细胞的分离方法 |
| CN103131634A (zh) * | 2013-02-25 | 2013-06-05 | 宁波美晶医疗技术有限公司 | 一种基于微磁场的免疫肿瘤细胞筛选系统 |
| CN103940997A (zh) * | 2014-03-21 | 2014-07-23 | 上海柏慧康生物科技有限公司 | 一种乳腺癌循环肿瘤细胞检测系统及试剂盒 |
| CN115655825A (zh) * | 2015-09-18 | 2023-01-31 | 紫荆实验室股份有限公司 | 利用表面附着结构的流动池，以及相关的系统和方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2421654A1 (en) | 2012-02-29 |
| AU2010239154A1 (en) | 2011-11-10 |
| RU2011147219A (ru) | 2013-05-27 |
| US20120115167A1 (en) | 2012-05-10 |
| WO2010121315A1 (en) | 2010-10-28 |
| NZ595982A (en) | 2013-10-25 |
| JP2012524885A (ja) | 2012-10-18 |
| IL215807A0 (en) | 2012-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102458665A (zh) | 用于从生物学样品中分离靶生物实体的方法和仪器 | |
| CN109870582B (zh) | 一种多靶标磁免疫化学发光微流控芯片检测平台及方法 | |
| US10444125B2 (en) | Devices and methods for separating magnetically labeled moieties in a sample | |
| US8263387B2 (en) | Sheath flow devices and methods | |
| US9588117B2 (en) | Detecting cells secreting a protein of interest | |
| US20090053799A1 (en) | Trapping magnetic sorting system for target species | |
| JP2005528584A (ja) | フロー制御された磁性粒子の操作 | |
| JP2005521425A5 (https=) | ||
| US20140170669A1 (en) | Devices for target detection and methods of use thereof | |
| US20100233675A1 (en) | Analyte manipulation and detection | |
| JP2000500871A (ja) | 生物学的分析用流体内の磁気粒子の分離方法及び設備ならびにその方法の応用 | |
| WO2017053630A1 (en) | Centrifuge-free isolation and detection of rare cells | |
| JPWO2017213080A1 (ja) | 流体デバイス、システム、試料物質の検出方法および試料物質の精製方法 | |
| KR101639862B1 (ko) | 식중독균 신속 검출을 위한 초고효율 자성 나노입자 포집 장치 | |
| WO2012113028A1 (en) | Isolation of a target bioentity from a biological sample | |
| JP2003227830A (ja) | 生物流体を研究するための検査システム |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120516 |